Resolutions of the Annual Combined Shareholders' Meeting of Sartorius Stedim Biotech S.A.
April 03 2018 - 9:30AM
Business Wire
Regulatory News:
At today’s Annual General Shareholders' Meeting (AGM) of
Sartorius Stedim Biotech S.A. (Paris:DIM) in Aubagne, France,
shareholders passed the resolution to pay a dividend of €0.46 per
share for fiscal 2017. The previous year’s dividend was €0.42 per
share. The total profit distributed will therefore rise by 9.6%
from €38.7 million to €42.4 million.
Furthermore, the Annual General Shareholders´ Meeting ratified
the cooptation of Dr. Lothar Kappich as Director of the company. In
September 2017, Lothar Kappich replaced Professor Arnold Picot, who
had passed away on July 9, 2017. Kappich’s directorship will last
for one more year. In addition, the Annual General Shareholders’
Meeting approved the renewal of the appointments of Susan Dexter
and Anne-Marie Graffin as Directors, each for a three-year
term.
This press release contains statements about the future
development of the Sartorius Stedim Biotech Group. We cannot
guarantee that the content of these statements will actually apply
because these statements are based upon assumptions and estimates
that harbor certain risks and uncertainties.
A profile of Sartorius Stedim Biotech
Sartorius Stedim Biotech is a leading international supplier of
products and services that enable the biopharmaceutical industry to
develop and manufacture drugs safely and efficiently. As a total
solutions provider, Sartorius Stedim Biotech offers a portfolio
covering nearly all steps of biopharmaceutical manufacture. The
company focuses on single-use technologies and value-added services
to meet the rapidly changing technology requirements of the
industry it serves. Headquartered in Aubagne, France, Sartorius
Stedim Biotech is quoted on the Eurolist of Euronext Paris. With
its own manufacturing and R&D sites in Europe, North America
and Asia and an international network of sales companies, Sartorius
Stedim Biotech has a global reach. In 2017, the company employed
approx. 5,100 people, and earned sales revenue of €1,081.0
million.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180403005829/en/
Sartorius Stedim Biotech S.A.Petra KirchhoffVice
President of Corporate Communications and IR+49
(0)551.308.1686petra.kirchhoff@sartorius.comwww.sartorius-stedim.com
Sartorius Stedim Biotech (EU:DIM)
Historical Stock Chart
From May 2024 to May 2024
Sartorius Stedim Biotech (EU:DIM)
Historical Stock Chart
From May 2023 to May 2024
